Angelman Syndrome (AS) is characterized by severe developmental delays including
marked speech impairment, movement abnormalities (ataxia, tremor), and unique behaviors …

Angelman syndrome is a neurogenetic disorder caused by lack of UBE3A gene expression
from the maternally inherited chromosome 15 due to various 15q11-q13 abnormalities. In …

This paper reviews Angelman syndrome (AS) with regard to the clinical features in
childhood and adulthood, epileptic seizures and EEG findings, neuroimaging studies and …

Angelman syndrome (AS) has emerged as an important neurogenetic syndrome due to its
relatively high prevalence and easier confirmation of the diagnosis by improved genetic …

Angelman syndrome (AS) is a distinct neurogenetic syndrome, first described in 1965. The
phenotype is well known in infancy and adulthood, but the clinical features may change with …

Half a century ago, Harry Angelman reported three patients with overlapping clinical
features, now well known as Angelman syndrome. Angelman syndrome is caused by …

Angelman syndrome is a rare neurogenetic disorder that is characterized by microcephaly,
severe intellectual deficit, speech impairment, epilepsy, EEG abnormalities, ataxic …

Angelman syndrome (AS) is a rare neurodevelopmental disease that is caused by the loss
of function of the maternal copy of ubiquitin–protein ligase E3A (UBE3A) on the …

Angelman syndrome (AS) is a neurogenetic imprinting disorder caused by loss of the
maternally inherited Ube3a gene and is characterized by generalized epilepsy, limited …

Angelman syndrome is a neurogenetic disorder characterized by the loss or reduction of the
ubiquitin-protein ligase E3A enzyme. Angelman syndrome results from a deletion or …